GW870086

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GW870086, covering 2017-07-21 to 2017-07-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study Assessing GW870086's Potential to Cause Skin Thinning [Phase 1]